SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
+14.78%
1 Year Return
+26.83%
3 Year Return
+97.04%
5 Year Return
+189.63%
10 Year Return
–
AUM
$13.3B
AUM Growth
-$1.61B
(-11%)
Cap. Flow
-$2.99B
Cap. Flow
% of AUM
-22.55%
Top 10 Holdings %
Top 10 Hldgs %
19.71%
Holding
2,546
New
501
Increased
701
Reduced
653
Closed
659
Top Buys
| 1 |
Caterpillar
CAT
|
+$110M |
| 2 |
NVIDIA
NVDA
|
+$94.7M |
| 3 |
ARK 21Shares Bitcoin ETF
ARKB
|
+$92.2M |
| 4 |
CSX Corp
CSX
|
+$83M |
| 5 |
TSMC
TSM
|
+$73.1M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.42B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$523M |
| 3 |
Meta Platforms (Facebook)
META
|
+$197M |
| 4 |
Vertiv
VRT
|
+$114M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$102M |
Sector Composition
| 1 | Technology | 16.68% |
| 2 | Industrials | 15.95% |
| 3 | Financials | 10.39% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Healthcare | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
CVS Health
CVS
$98.8B
| $10M | 0.07% |
145,458
+1,416
|
|
||
302
Vale
VALE
$45.9B
| $10M | 0.07% |
1,032,180
+183,631
|
|
||
303
Target
TGT
$38.9B
| $9.89M | 0.07% |
100,239
+86,261
|
|
||
304
Macerich
MAC
$4.17B
| $9.77M | 0.07% |
603,934
-664,627
|
|
||
305
Abbott
ABT
$231B
| $9.76M | 0.07% |
71,744
+55,026
|
|
||
306
Jabil
JBL
$20.8B
| $9.73M | 0.07% |
44,626
+25,979
|
|
||
|
COOP
307
DELISTED
Mr. Cooper
COOP
| $9.71M | 0.07% |
65,091
+58,205
|
|
||
308
Garmin
GRMN
$47.7B
| $9.68M | 0.07% |
46,360
+30,039
|
|
||
309
McDonald's
MCD
$212B
| $9.67M | 0.07% |
33,106
-59,554
|
|
||
310
Charles River Laboratories
CRL
$8.22B
| $9.65M | 0.07% |
63,587
+61,677
|
|
||
311
Dick's Sporting Goods
DKS
$19B
| $9.62M | 0.07% |
48,623
-56,431
|
|
||
312
Thomson Reuters
TRI
$68.2B
| $9.62M | 0.07% |
47,808
-32,273
|
|
||
313
Albemarle
ALB
$10.6B
| $9.6M | 0.07% |
153,153
-2,981
|
|
||
314
Edwards Lifesciences
EW
$43.4B
| $9.58M | 0.07% |
122,507
-338,741
|
|
||
315
Entergy
ETR
$42.5B
| $9.58M | 0.07% |
115,268
+63,923
|
|
||
316
KKR & Co
KKR
$105B
| $9.58M | 0.07% |
72,002
-166,552
|
|
||
|
BASE
317
DELISTED
Couchbase
BASE
| $9.56M | 0.07% |
+392,255
|
|
||
318
Willis Towers Watson
WTW
$32.9B
| $9.56M | 0.06% |
31,176
+5,104
|
|
||
319
Stride
LRN
$6.31B
| $9.52M | 0.06% |
65,590
+10,766
|
|
||
320
Clorox
CLX
$14.6B
| $9.44M | 0.06% |
78,635
+60,071
|
|
||
321
DaVita
DVA
$8.87B
| $9.4M | 0.06% |
+66,008
|
|
||
322
Pinnacle West Capital
PNW
$11B
| $9.25M | 0.06% |
103,348
+24,591
|
|
||
323
Zeekr
ZK
$7.35B
| $9.24M | 0.06% |
+362,257
|
|
||
324
Neurocrine Biosciences
NBIX
$13.6B
| $9.17M | 0.06% |
72,945
+65,782
|
|
||
325
Lamb Weston
LW
$8.88B
| $9.15M | 0.06% |
176,384
-136,425
|
|